Tags

Type your tag names separated by a space and hit enter

Mid-term results for the retroluminar transobturator sling suspension for stress urinary incontinence after prostatectomy.
BJU Int. 2011 Jul; 108(1):94-8.BI

Abstract

OBJECTIVE

• To evaluate prospectively the efficacy of the retroluminar transobturator male sling (AdVance® sling) for the functional treatment of stress urinary incontinence (SUI) after prostatectomy.

PATIENTS AND METHODS

• A total of 137 patients with grade II-IV SUI, resulting from radical prostatectomy, were treated with the AdVance® sling in a prospective clinical study. In all, 11 patients were lost to follow-up. A total of 17 patients (13.5%) had additional adjuvant radiotherapy before sling implantation. • Before and after sling implantation, a standardized 1-h pad test was performed and post-void residual urine, uroflowmetry, quality-of-life scores and the International Index of Erectile Function (IIEF-5) were assessed. • When calculating the cure and improvement rates, 'cure' was defined as no pad use or one dry prophylactic pad; and 'improved' was defined as 1-2 pads or reduction of pads ≥ 50%.

RESULTS

• After a median (range) follow-up of 27 (20-37) months, and a mean follow-up of 27.2 months, the success rate was 75.4% with 51.6%'cured' and 23.8%'improved'. • Overall daily pad use, urine loss in the 1-h pad test and quality-of-life scores improved significantly after sling implantation. • Compared with 1-year follow-up data, no worsening over time was noticed and no additional complications were seen.

CONCLUSION

• With a mid-term follow-up, the retroluminar transobturator male sling is an effective, safe and attractive treatment option for SUI after radical prostatectomy. Results are stable over time.

Links

Aggregator Full Text

Authors+Show Affiliations

Bauer RM
Department of Urology, Ludwig-Maximilian-University, Munich, Germany. Ricarda.Bauer@med.uni-muenchen.de
Soljanik I
No affiliation info available
Füllhase C
No affiliation info available
Karl A
No affiliation info available
Becker A
No affiliation info available
Stief CG
No affiliation info available
Gozzi C
No affiliation info available

MeSH

AgedAged, 80 and overEpidemiologic MethodsHumansMaleMiddle AgedProstatectomyQuality of LifeSuburethral SlingsTreatment OutcomeUrinary Incontinence, Stress

Pub Type(s)

Evaluation Study
Journal Article

Language

eng

PubMed ID

20883489

Citation

Bauer, Ricarda M., et al. "Mid-term Results for the Retroluminar Transobturator Sling Suspension for Stress Urinary Incontinence After Prostatectomy." BJU International, vol. 108, no. 1, 2011, pp. 94-8.
Bauer RM, Soljanik I, Füllhase C, et al. Mid-term results for the retroluminar transobturator sling suspension for stress urinary incontinence after prostatectomy. BJU Int. 2011;108(1):94-8.
Bauer, R. M., Soljanik, I., Füllhase, C., Karl, A., Becker, A., Stief, C. G., & Gozzi, C. (2011). Mid-term results for the retroluminar transobturator sling suspension for stress urinary incontinence after prostatectomy. BJU International, 108(1), 94-8. https://doi.org/10.1111/j.1464-410X.2010.09729.x
Bauer RM, et al. Mid-term Results for the Retroluminar Transobturator Sling Suspension for Stress Urinary Incontinence After Prostatectomy. BJU Int. 2011;108(1):94-8. PubMed PMID: 20883489.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Mid-term results for the retroluminar transobturator sling suspension for stress urinary incontinence after prostatectomy. AU - Bauer,Ricarda M, AU - Soljanik,Irina, AU - Füllhase,Claudius, AU - Karl,Alexander, AU - Becker,Armin, AU - Stief,Christian G, AU - Gozzi,Christian, Y1 - 2010/09/30/ PY - 2010/10/2/entrez PY - 2010/10/5/pubmed PY - 2011/8/13/medline SP - 94 EP - 8 JF - BJU international JO - BJU Int VL - 108 IS - 1 N2 - OBJECTIVE: • To evaluate prospectively the efficacy of the retroluminar transobturator male sling (AdVance® sling) for the functional treatment of stress urinary incontinence (SUI) after prostatectomy. PATIENTS AND METHODS: • A total of 137 patients with grade II-IV SUI, resulting from radical prostatectomy, were treated with the AdVance® sling in a prospective clinical study. In all, 11 patients were lost to follow-up. A total of 17 patients (13.5%) had additional adjuvant radiotherapy before sling implantation. • Before and after sling implantation, a standardized 1-h pad test was performed and post-void residual urine, uroflowmetry, quality-of-life scores and the International Index of Erectile Function (IIEF-5) were assessed. • When calculating the cure and improvement rates, 'cure' was defined as no pad use or one dry prophylactic pad; and 'improved' was defined as 1-2 pads or reduction of pads ≥ 50%. RESULTS: • After a median (range) follow-up of 27 (20-37) months, and a mean follow-up of 27.2 months, the success rate was 75.4% with 51.6%'cured' and 23.8%'improved'. • Overall daily pad use, urine loss in the 1-h pad test and quality-of-life scores improved significantly after sling implantation. • Compared with 1-year follow-up data, no worsening over time was noticed and no additional complications were seen. CONCLUSION: • With a mid-term follow-up, the retroluminar transobturator male sling is an effective, safe and attractive treatment option for SUI after radical prostatectomy. Results are stable over time. SN - 1464-410X UR - https://www.unboundmedicine.com/medline/citation/20883489/Mid_term_results_for_the_retroluminar_transobturator_sling_suspension_for_stress_urinary_incontinence_after_prostatectomy_ L2 - https://doi.org/10.1111/j.1464-410X.2010.09729.x DB - PRIME DP - Unbound Medicine ER -